Eikon has a growing therapeutic pipeline with the potential to deliver important new medicines to address serious illnesses, many with severely unmet medical needs. We have clinical programs that have already provided evidence of activity in the treatment of solid tumors.

Our research teams are rapidly advancing numerous preclinical programs across a broad range of therapeutic areas. Beyond oncology, 
we invest substantial effort in immunology and neuroscience.

Eikon has a growing therapeutic pipeline with the potential to deliver important new medicines to address serious illnesses, many with severely unmet medical needs. We have clinical programs that have already provided evidence of activity in the treatment of solid tumors.

Our research teams are rapidly advancing numerous preclinical programs across a broad range of therapeutic areas. Beyond oncology, 
we invest substantial effort in immunology and neuroscience.